Figure 4
Meta-analysis of drug related adverse events comparing ertapenem with piperacillin/tazobactam for complicated infections treatment during the treatment and the post-treatment period. The analysis based on safety evaluable population. A, analysis of clinical drug related adverse events; B, analysis of laboratory drug related adverse events; Vertical line indicates no difference between ertapenem and piperacillin/tazobactam. The size of each square denotes the proportion of information given by each trial.